The timing of referral and the severity of condition in patients with lung damage and suspected novel coronavirus infection on admission to hospital during the beginning of the pandemic


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

During the beginning of the pandemic, when a patient with lung damage was admitted to a hospital unit of pulmonology, the algorithm of a physician’s actions included diagnosis of coronavirus infection (COVID-19), determination of the severity of condition, and hospitalization decision. Objective: to study the severity of condition in patients with lung damage and a high probability of the novel coronavirus infection and the timing of referral to the general hospital’s unit of pulmonology during the beginning of the pandemic. Subjects and methods. According to the hospital admission time after disease onset, the investigators formed 2 groups: 1) less than 7 days after disease onset (n = 94); 2) more than 7 days (n = 49). Reverse transcriptase polymerase chain reaction (RT-PCR) and chest computed tomography (CT) were used to diagnose lung damage with a high probability of COVID-19 infection. Results. The majority of patients were admitted within the first week after the onset of symptoms (66%), while 55% of cases had moderate disease. The swabs positive for SARS-CoV-2 were 32%. At the initial stage of the novel coronavirus (COVID-19) infection pandemic, there were no significant differences in lung damage with negative and positive PCR test results for SARS-CoV-2. By taking into account the commonness of manifestations in lung damages, the patients with a negative PCR test for SARS-CoV-2 were diagnosed with the novel coronavirus COVID-19 infection that was highly probable by CT, which allowed a decision to transfer a healthcare facility to the operating mode of a coronavirus hospital.

Full Text

Restricted Access

About the authors

E. S Vdoushkina

Samara State Medical University Ministry of Health of Russia

Email: borodulinbe@yandex.ru
Candidate of Medical Sciences

E. A Borodulina

Samara State Medical University Ministry of Health of Russia

Email: borodulinbe@yandex.ru
Professor, MD

L. V Povalyaeva

Samara State Medical University Ministry of Health of Russia

Email: borodulinbe@yandex.ru
Candidate of Medical Sciences

A. V Sukhanova

Samara State Medical University Ministry of Health of Russia

Email: borodulinbe@yandex.ru

K. V Zhilinskaya

Samara State Medical University Ministry of Health of Russia

Email: borodulinbe@yandex.ru

A. V Sutyagin

Samara State Medical University Ministry of Health of Russia

Email: borodulinbe@yandex.ru

References

  1. Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr. 2020; 87 (4): 281-6. doi: 10.1007/s12098-020-03263-6
  2. Teo J. Early Detection of Silent Hypoxia in Covid-19 Pneumonia Using Smartphone Pulse Oximetry. J Med Syst. 2020; 44 (8): 134. doi: 10.1007/s10916-020-01587-6.
  3. Бородулина Е.А., Широбоков Я.Е., Гладунова Е.П. и др. Диагностика и фармакотерапия вирус-ассоциированных поражений легких. Клиническая фармакология и терапия 2020; 29 (4): 61-6. doi: 10.32756/0869-5490-2020-3-61-66
  4. Rothe C., Schunk M., Sothmann P. et al. Transmission of 2019-nCoV infection from asymptomatic contact in Germany. N Engl J Med. 2020; 382 (10): 970-1. doi: 10.1056/NEJMc2001468
  5. Ihle-Hansen H., Berge T., Tveita A. et al. COVID-19: Symptoms, course of illness and use of clinical scoring systems for the first 42 patients admitted to a Norwegian local hospital. Tidsskr Nor Laegeforen. 2020; 140 (7). doi: 10.4045/tidsskr.20.0301
  6. Самородская И.В., Ключников И.В. Проблемы диагностики и лечения COVID-19 на клиническом примере. Врач. 2020; 31 (4): 19-25 doi: 10.29296/25877305-2020-04-04
  7. Кудлай Д.А., Широбоков Я.Е., Гладунова Е.П. и др. Диагностика COVID-19. Способы и проблемы обнаружения вируса SARS-COV-2 в условиях пандемии. Врач. 2020; 31 (8): 5-10. https://doi.org/10.29296/25877305-2020-08-01
  8. Старшинова А.А., Кушнарева Е.А., Малкова А.М. и др. Новая коронавирусная инфекция: особенности клинического течения, возможности диагностики, лечения и профилактики инфекции у взрослых и детей. Вопросы современной педиатрии. 2020; 19(2): 123-31. https://doi.org/10.15690/vsp.v19i2.2105
  9. Fang Y., Zhang H., Xu Y. et al. CT Manifestations of Two Cases of 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology. 2020; 295 (1): 208-9. doi: 10.1148/radiol.2020200280
  10. Pan F., Ye T., Sun P. et al. Time course of lung changes on chest CT during recovery from 2019 Novel Coronavirus (COVID-19) pneumonia. Radiology. 2020; 295 (3): 715-21. doi: 10.1148/radiol.2020200370
  11. Mungmunpuntipantip R., Wiwanitkit V. Uncertainty in using chest computed tomography in early coronavirus disease (COVID-19). Can J Anaesth. 2020; 67 (7): 897. doi: 10.1007/s12630-020-01639-y
  12. Onder G., Rezza G., Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020; 323 (18): 1775-6. doi: 10.1001/jama.2020.4683
  13. Singh A.K., Gupta R., Misra A. Comorbidities in COVID-19: outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. Diabetes Metab Syndr. 2020; 14 (4): 283-7. doi: 10.1016/j.dsx.2020.03.016
  14. Yang J., Zheng Y., Gou X. et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020; 94: 91-5. doi: 10.1016/j.ijid.2020.03.017
  15. Chan-Yeung M., Xu R.H. SARS: epidemiology. Respirology. 2003; 8 (Suppl. 1): S9-14. doi: 10.1046/j.1440-1843.2003.00518.x
  16. Zou L., Ruan F., Huang M. et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med. 2020; 382 (12): 1177-9. doi: 10.1056/NEJMc2001737

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2020 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies